DK116657B - Analogifremgangsmåde til fremstilling af terapeutisk aktive 3-(2'-chlorethylthio)-6-cyano-3,5-pregnadiener. - Google Patents
Analogifremgangsmåde til fremstilling af terapeutisk aktive 3-(2'-chlorethylthio)-6-cyano-3,5-pregnadiener.Info
- Publication number
- DK116657B DK116657B DK44568AA DK44568A DK116657B DK 116657 B DK116657 B DK 116657B DK 44568A A DK44568A A DK 44568AA DK 44568 A DK44568 A DK 44568A DK 116657 B DK116657 B DK 116657B
- Authority
- DK
- Denmark
- Prior art keywords
- pregnadienes
- chloroethylthio
- cyano
- preparation
- therapeutically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1233267 | 1967-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK116657B true DK116657B (da) | 1970-02-02 |
Family
ID=11139672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK44568AA DK116657B (da) | 1967-02-07 | 1968-02-06 | Analogifremgangsmåde til fremstilling af terapeutisk aktive 3-(2'-chlorethylthio)-6-cyano-3,5-pregnadiener. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3513161A (fr) |
| BE (1) | BE710410A (fr) |
| CH (1) | CH512457A (fr) |
| DE (1) | DE1668661C3 (fr) |
| DK (1) | DK116657B (fr) |
| FR (1) | FR7339M (fr) |
| GB (1) | GB1169134A (fr) |
| NL (2) | NL6801283A (fr) |
| SE (1) | SE325569B (fr) |
-
0
- NL NL135951D patent/NL135951C/xx active
-
1968
- 1968-01-29 NL NL6801283A patent/NL6801283A/xx unknown
- 1968-02-02 US US702515A patent/US3513161A/en not_active Expired - Lifetime
- 1968-02-02 DE DE1668661A patent/DE1668661C3/de not_active Expired
- 1968-02-02 GB GB5334/68A patent/GB1169134A/en not_active Expired
- 1968-02-02 FR FR138470A patent/FR7339M/fr not_active Expired
- 1968-02-06 DK DK44568AA patent/DK116657B/da unknown
- 1968-02-06 CH CH168968A patent/CH512457A/de not_active IP Right Cessation
- 1968-02-06 BE BE710410D patent/BE710410A/xx unknown
- 1968-02-06 SE SE01522/68A patent/SE325569B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH512457A (de) | 1971-09-15 |
| NL135951C (fr) | |
| DE1668661A1 (de) | 1971-09-30 |
| BE710410A (fr) | 1968-08-06 |
| FR7339M (fr) | 1969-10-13 |
| SE325569B (fr) | 1970-07-06 |
| DE1668661B2 (de) | 1973-05-17 |
| NL6801283A (fr) | 1968-08-08 |
| GB1169134A (en) | 1969-10-29 |
| US3513161A (en) | 1970-05-19 |
| DE1668661C3 (de) | 1973-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK128353B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner. | |
| FI49300C (fi) | Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi. | |
| DK124826B (da) | Analogifremgangsmåde til fremstilling af 1,2,4-oxadiazolforbindelser. | |
| FI49720C (fi) | Menetelmä terapeuttisesti vaikuttavien 2-metyyli-3-karbonihappoamidoki noksaliini-di-N-oksidien-(1,4) valmistamiseksi. | |
| DK129234B (da) | Fremgangsmåde til fremstilling af levo-1-n-butyl-2',6'-pipecoloxylidid. | |
| DK117635B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler. | |
| FI49718C (fi) | Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi. | |
| DK116656B (da) | Analogifremgangsmåde til fremstilling af 11-oxygenerede 3-(2'-chlorethylthio)-6-formyl-9α-fluor-3,5-pregnadien-20-oner. | |
| DK122760B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 4-alkoxy-3,5-dimethoxybenzamider. | |
| DK118246B (da) | Analogifremgangsmåde til fremstilling af 2-isothiuroniummethyl-3-carboxylsyreamido-quinozalin-di-N-oxid-(1,4)-halogenider. | |
| DK119166B (da) | Fremgangsmåde til fremstilling af 1,4-bezodiazepinderivater. | |
| DK122129B (da) | Analogifremgangsmåde til fremstilling af N,N'-dialkyl-4-phenylimidazolin-2-thioner. | |
| DK120134B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive 5-substituerede 2-(5-nitrofuryl-2)-pyrimidiner. | |
| DK119609B (da) | Analogifremgangsmåde til fremstilling af 2α,2β, 17α-trimethyl-13β-alkylgona-4,9,11-trien-17β-oler. | |
| DK116657B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive 3-(2'-chlorethylthio)-6-cyano-3,5-pregnadiener. | |
| DK126936B (da) | Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener. | |
| DK114962B (da) | Fremgangsmåde til fremstilling af α, α, α', α'-tetramethyl-xylylen-dicarbinoler. | |
| DK124679B (da) | Analogifremgangsmåde til fremstilling af hjertevirksomme 4,5-epoxy-14β-hydroxybufa-20,22-dienolider. | |
| FI48842C (fi) | Menetelmä farmakologisesti aktiivisten 6-kloori-1H-2,3-bentsoksatsiini en valmistamiseksi. | |
| DK116658B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener. | |
| FI46066C (fi) | Analogiamenetelmä terapeuttisesti vaikuttavien N,N-dimetyyliamino-etyy li-14beta-hydroksi-5beta-pregn-20-eeni-21-karboksylaattien valmistamis eksi. | |
| DK125083B (da) | Fremgangsmåde til fremstilling af 2,3-diklor-4-butyryl-fenoxyeddikesyre. | |
| DK121510B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5(10)>-østrener. | |
| DK116368B (da) | Fremgangsmåde til fremstilling af 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol. | |
| DK122763B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive 1,2α-methylen-4-pregnen-3,20-dionderivater. |